Aktuell 21. Nov. 2023 CRISPR Therapeutics und Vertex erhalten historische Zulassung Die Partner CRISPR Therapeutics und Vertex haben in Grossbritannien die weltweit erste Zulassung einer Therapie erreicht, die auf Genom-Editie...
News 19. Dez. 2023 Top Stories from Western Switzerland (October-December 2023) From achieving top rankings in global innovation to making significant advancements in healthcare and technology, discover Western Switzerland's ...
Aktuell 27. Nov. 2023 Boehringer Ingelheim übernimmt T3 Pharma Boehringer Ingelheim hat T3 Pharma mit Sitz im Switzerland Innovation Park Basel Area für bis zu 450 Millionen Franken erworben. Der Spezialist f...
News 18. Dez. 2023 UPM Biomedicals chooses the Basel Area as European bridgehead UPM Biomedicals is opening a lab on the Main Campus of Switzerland Innovation Park Basel Area. The Finnish company specializes in nanofibrillar c...
News 20. Dez. 2023 Proteomedix and Blue Water Biotech jointly found Onconetix Proteomedix has been acquired by Blue Water Biotech, which is based in Cincinnati in the US State of Ohio. The two firms have now jointly founded...
News 13. Dez. 2023 Macrogen establishes foothold in Basel Macrogen Europe is set to move into the Novartis Campus of Switzerland Innovation Park Basel Area. As with its parent company, the South Korean b...
News 19. Apr. 2022 CDR-Life receives 76 million US dollars The biotech company CDR-Life has concluded a series A funding round with 76 million US dollars. This is intended to be used for further developme...
Aktuell 01. Nov. 2023 Palto Therapeutics erhält 150'000 Franken von Venture Kick Palto Therapeutics hat die dritte Stufe des Förderprogramms von Venture Kick gewonnen. Das Start-up erhält für sein RNA-basiertes Krebstherapie-P...
News 06. Juni 2023 Novocure to donate 3 million US dollars to cancer research Novocure, a biotechnology firm specializing in the field of oncology, has pledged support of 1 million US dollars per year for a period of three ...
News 06. Okt. 2022 Biopôle expands further with the construction of three new buildings Biopôle has announced that Edmond de Rothschild Real Estate SICAV will be investing in the construction of three new buildings on the campus in E...
Headquarters 15. Juni 2023 Open Your HQ Are you a biopharmaceutical company seeking to access the European market? Switzerland could be the perfect location for your commercial headquar...
News 23. Mai 2023 University of Basel and RocketVax present new COVID vaccine Researchers from the University of Basel have developed a new concept for a COVID vaccine in collaboration with the biotech start-up RocketVax. I...
News 12. Dez. 2023 PharmaBiome and Ferring agree cooperation PharmaBiome and the biopharmaceutical firm Ferring from the canton of Vaud will in future each jointly develop and manufacture specific bacterial...
人材 23. Aug. 2023 人材 ライフサイエンス業界で優秀な人材をお探しですか?スイスは優秀な人材の宝庫として有名です。ライフサイエンス企業がスイスの膨大な人材プールから受けるメリットをご紹介します。
Spotlight 15. Juni 2023 Access to Ecosystem Switzerland is a global leader in biotech, medtech and pharma. Find out what makes the Swiss life science industry unique and how your life scien...
News 11. Dez. 2023 Artbio and Scailyte making headlines in Basel The biotech company Scailyte has raised 8 million US dollars as part of a Series A financing round. For its part, Artbio has raised as much as 90...
Talent 17. Mai 2024 Find Talent Are you looking for skilled personnel in the Life Science industry? Switzerland is famous for its highly qualified workforce. Find out how your L...